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To the Editor:
Multiple bile duct hamartoma [von Meyenburg complex
(VMC)] is a benign liver malformation that includes biliary
cystic lesions with congenital hepatic ﬁbrosis causing ductal
plate malformations (1–7). It is generally asymptomatic and
tends to be identiﬁed either at autopsy or during histological
examinations (1). We report a very rare case of severe portal
hypertension caused by VMC diagnosed by magnetic resonance
cholangiopancreatography (MRCP) and histopathology.
Case report
An 88-year-old female was hospitalized with hypoxic orthop-
noea, abdominal fullness and leg oedema. Arterial blood gas
analysis revealed 88% oxygen saturation. A chest X-ray revealed
a widespread right pleural effusion. Past history was unremark-
able. Laboratory tests showed normal liver chemistry except for
mild elevations of alkaline phosphatase and g-glutamyl trans-
peptidase. Antinuclear antibody and antimitochondrial-2 anti-
body were negative. Serology for hepatitis B virus, hepatitis C
virus and HIV were negative. Tumour markers showed: a-
foetoprotein, 2.4ng/ml (0–20ng/ml); carbohydrate antigen 19-
9, 56.6U/ml (0–37U/ml); and carcinoembryonic antigen,
9.0ng/ml (0–5.0ng/ml). Endoscopy revealed large oesophageal
varices in the mid-oesophagus. Abdominal computed tomo-
graphy revealed multiple cystic images in the whole liver and
both kidneys, some ascites and mild splenomegaly (Fig. 1A).
The intrahepatic and extrahepatic bile ducts were not dilated.
No evidence of cirrhosis, heart failure or renal dysfunction was
observed. Especially, brain natriuretic peptide, human atrial
natriuretic peptide and cardiac ejection fraction were normal.
Furthermore, no malignant lesion or vessel thrombus was seen.
MRCP T2-weighted sequences showed multiple small hyper-
intense lesions o1cm diameter and normal intrahepatic and
extrahepatic bile ducts (Fig. 1B). Inferior vena cavography and
hepatic venography showed no angiostenosis or thrombus in
the major blood vessels. Hepatic venous pressure gradient was
14mmHg. Therefore, VMC or multiple livercysts were strongly
suspected. A liver biopsy revealed diffuse bile duct hamartomas
arising in the portal region. Haematoxylin–eosin staining
showed bile duct microhamartomas consisting of circum-
scribed ﬁbrous areas containing many irregularly dilated bile
duct structures and only a few narrowed vessels in the portal
region (Fig. 1C). A narrowing of the portal vein might have
occurred. Therefore, a diagnosis of VMC with portal hyperten-
sion was conﬁrmed. We believe that the displacement of the
portal vein triggered portal hypertension. Furosemide therapy
rapidly improved the patient’s condition. One year later, the
patient’s condition has remained stable on diuretic treatment.
However, a follow-up endoscopy showed mid-oesophageal
varices unchanged from the previous.
Discussion
This is the ﬁrst report of a VMC patient with severe symptoms
due to portal hypertension. Magnetic resonance imaging is
generally useful for the diagnosis of VMC (2, 3). This condition
is incidentally detected in from 0.5 to 5.6% of autopsies (1) and
is generally asymptomatic. In contrast, our patient presented
with severe portal hypertension. It was thought that portal
hypertension was due to displacement of the portal vein by the
presence of VMC. As a result, severe pleural effusion, ascites
and oesophageal varices developed. Previous reports described
VMC cases with epigastric pain (4, 5). However, those were not
pure VMC cases.
In contrast, there are only a few published VMC reports
supporting the current ﬁndings (5–7). Brancatelli et al. (7)
described portal hypertension that occurred from ﬁbropolycys-
tic liver disease. Their observations are helpful for our clinical
perspective. Despite furosemide treatment, oesophageal varices
remained unchanged, indicating the presence of persisting
portal hypertension in the setting of VMC.
In conclusion, VMC can trigger severe symptoms requiring
urgent and continuous treatment. The present case therefore
fell outside of the traditional diagnostic criteria and manage-
ment guidelines for VMC. These ﬁndings suggest that the
concept of VMC may require modiﬁcation because it does not
apply to all cases. In addition, the clinicopathological and
Liver International (2009)
614 c  2009 The Authors. Journal compilation c  2009 Blackwell Publishing Ltd
Liver International ISSN 1478-3223radiological features of VMC, as well as the pathogenesis need
further study and clariﬁcation.
Shuhei Yoshida
1,2, Kazutaka Kurokohchi
2, Takuya Ueno
3,
Morihiko Yoshino
1, Masahiko Shimada
1 and Tsutomu Masaki
2
1 Department of Gastroenterology, Internal Medicine, TMG
Asakadai Central General Hospital,
Saitama, Japan
2 Division of Gastroenterology and Hepatology, Internal
Medicine, Kagawa University School of Medicine, Kagawa, Japan
3 Critical Care Medicine, Hachioji Medical Center, Tokyo Medical
University, Tokyo, Japan
References
1. Redston MS, Wanless IR. The hepatic von Meyenburg complex:
prevalence and association with hepatic and renal cysts among 2843
autopsies. Mod Pathol 1996; 9: 233–7.
2. Zheng RQ, Zhang B, Kudo M, Onda H, Inoue T. Imaging ﬁndings of
biliary hamartomas. World J Gastroenterol 2005; 11: 6354–9.
3. Ye BB, Hu B, Wang LJ, et al. Mesenchymal hamartoma of liver:
magestic resonance imaging and histopathologic correlation. World J
Gastroenterol 2005; 11: 5807–10.
4. R¨ ocken C, Pross M, Brucks U, Ridwelski K, Roessner A. Cholamgio-
carcinoma occurring in a liver with multiple Bile Duct Hamartomas
(von Meyenburg complexes). Arch Pathol Lab Med 2000; 124:
1704–6.
5. Karahan OI, Kahriman G, Soyuer I, Ok E. Hepatic von Meyenburg
complex simulating biliary cystadenocarcinoma. Clin Imaging 2007;
31: 50–3.
6. Jain D, Sarode VR, Abdul-Karim FW, et al. Evidence for the
neoplastic transformation of Von-Meyenburg complexes. Am J Surg
Pathol 2000; 24: 1131–9.
7. Brancatelli G, Federle MP, Vilgrain V, et al. Fibropolycystic liver
disease: CT and MR imaging ﬁndings. Radiographics 2005; 25:
659–70.
Fig. 1. (A) Axial computed tomography 4242mm (300300DPI).
(B) T2-weighted magnetic resonance cholangiogram shows numerous
high-signal-intensity liver lesions and no communication between
these and the normal-sized intra- and extrahepatic biliary system.
4242mm (300300DPI). (C) Photomicrograph (original
magniﬁcation, 40; H&E stain) shows a portal region (arrowheads)
containing several cystic spaces, which are interspersed with ﬁbrous
stroma and lined by a layer of biliary epithelium (arrows). 8463mm
(300300DPI).
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